Dr. Dale Bredesen
MD (Duke University Medical Center, UCSF) — Buck Institute for Research on Aging, Apollo Health. Focusing on neurodegenerative reversal, synaptic rebuilding, recode / bredesen protocol. Author of The End of Alzheimer's (2017), The First Survivors of Alzheimer's (2021).
Submitted Protocols
ReCODE Synaptic Preservation & Ketoflex 12/3 Protocol
A precision systems biology program (ReCODE) combining a 12-hour overnight fast with 3 hours pre-sleep fasting (KetoFLEX 12/3), mild nutritional ketosis, trophic hormone optimization, oral microbiome cleansing, and homocysteine regulation to prevent synaptic pruning.
Dr. Dale Bredesen: Signature Wellness Protocol
Precision multi-modal metabolic support (ReCODE) addressing trophic support, toxins, and inflammation Primary Focus: Neurodegenerative reversal, synaptic rebuilding, ReCODE / Bredesen Protocol. Key Works: The End of Alzheimer's (2017); The First Survivors of Alzheimer's (2021).
Recent Threads
ReCODE protocol: Addressing 36 metabolic contributors to cognitive decline
8mo agoA precision systems biology program (ReCODE) combining a 12-hour overnight fast with 3 hours pre-sleep fasting (KetoFLEX 12/3), mild nutritional ketosis, trophic hormone optimization, oral microbiome cleansing, and homocysteine regulation to prevent synaptic pruning. Primary Citation: The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline (2017). Verified Public Record: "Cognitive decline is not a single disease entity; it is the brain's downstream downsizing response to 36 distinct metabolic insults, nutrient deficiencies, and systemic inflammatory triggers." — The End of Alzheimer's (Chapter 3: The 36 Holes in the Roof, p. 58 (2017))
Dr. Dale Bredesen on Neurodegenerative reversal
11mo agoCore perspective shared by Dr. Dale Bredesen (Buck Institute for Research on Aging, Apollo Health): "Precision multi-modal metabolic support (ReCODE) addressing trophic support, toxins, and inflammation" Key Works: The End of Alzheimer's (2017), The First Survivors of Alzheimer's (2021).